The Medical Devices sector report, “Intravascular Ultrasound Systems (IVUS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Intravascular Ultrasound Systems (IVUS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Intravascular Ultrasound System is a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy and intravascular ultrasound combined system intended to identify and characterize atherosclerotic plaque in the coronary arteries. It is a combination device that uses IVUS to quantify the degree of narrowing produced by a plaque, the size of the artery and the adequacy of stent expansion.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Intravascular Ultrasound System is a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy and intravascular ultrasound combined system intended to identify and characterize atherosclerotic plaque in the coronary arteries. It is a combination device that uses IVUS to quantify the degree of narrowing produced by a plaque, the size of the artery and the adequacy of stent expansion.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Intravascular Ultrasound Systems (IVUS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Intravascular Ultrasound Systems (IVUS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Intravascular Ultrasound Systems (IVUS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Intravascular Ultrasound Systems (IVUS) - Pipeline Products under Development by Companies
5 Intravascular Ultrasound Systems (IVUS) Companies and Product Overview
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AccuPulse Medical Technology Co Ltd
- Arbor Ultrasound Technologies, LLC (Inactive)
- Biosense Webster Inc
- Boston Scientific Corp
- Covidien Ltd
- Evident Vascular Inc
- Georgia Institute of Technology
- Intravascular Imaging Inc
- Kaminari Medical BV
- Koninklijke Philips NV
- MicroPort Scientific Corp
- North Carolina State University
- Novosound Ltd
- OCT Medical Imaging Inc
- Panoramic Hengsheng (Beijing) Science and Technology Co Ltd
- RadioSon Corporation
- Shanghai Pulse Medical Technology Inc
- Shenzhen Huanying Medical Technology Co Ltd
- Shenzhen Saihe Medical Technology Co Ltd
- SIBUS Medical Inc (Inactive)
- SoniVie Ltd.
- Soundpipe LLC
- Stelect Pty Ltd
- Terumo Corp
- The University of Texas at Austin Division of Housing and Food Service
- University of Cincinnati
- University of Oxford
- Versono Medical Ltd
